HELX vs. IBBQ

Last updated Jun 24, 2026

HELX (Franklin Genomic Advancements ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) are both Health & Biotech Equities funds. HELX is actively managed, while IBBQ is passively managed. Over the past 5 years, HELX returned -5.27%/yr vs 4.77%/yr for IBBQ. Their correlation of 0.85 suggests significant overlap in exposure. HELX charges 0.50%/yr vs 0.00%/yr for IBBQ.

Performance

HELX vs. IBBQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Franklin Genomic Advancements ETF (HELX) and Invesco Nasdaq Biotechnology ETF (IBBQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HELX achieves a 0.89% return, which is significantly lower than IBBQ's 8.67% return.

HELX

• 1D: 0.84%
• 1M: 7.10%
• YTD: 0.89%
• 6M: -0.79%
• 1Y: 35.07%
• 3Y*: 7.14%
• 5Y*: -5.27%
• 10Y*: —

IBBQ

• 1D: 0.93%
• 1M: 5.09%
• YTD: 8.67%
• 6M: 7.00%
• 1Y: 48.86%
• 3Y*: 15.18%
• 5Y*: 4.77%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HELX vs. IBBQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
HELX Franklin Genomic Advancements ETF	0.89%	26.34%	-5.32%	1.14%	-37.89%	4.19%
IBBQ Invesco Nasdaq Biotechnology ETF	8.67%	33.32%	-0.63%	4.73%	-10.41%	-6.24%

Correlation

The correlation between HELX and IBBQ is 0.83, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.83
Correlation (3Y) Calculated over the trailing 3-year period	0.86
Correlation (5Y) Calculated over the trailing 5-year period	0.85
Correlation (All Time) Calculated using the full available price history since Jun 11, 2021	0.85

The correlation between HELX and IBBQ has been stable across timeframes, ranging from 0.83 to 0.86 - a consistent structural relationship.

HELX vs. IBBQ - Sectors Allocation Comparison

Sectors	HELX	IBBQ
Healthcare	96.5%	99.9%
Basic Materials	2.4%	-
Technology	1.1%	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	0.1%
Industrials	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

HELX vs. IBBQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HELX

HELX Risk / Return Rank: 45
HELX Sharpe Ratio Rank: 51
HELX Sortino Ratio Rank: 52
HELX Omega Ratio Rank: 47
HELX Calmar Ratio Rank: 42
HELX Martin Ratio Rank: 35

IBBQ

IBBQ Risk / Return Rank: 83
IBBQ Sharpe Ratio Rank: 81
IBBQ Sortino Ratio Rank: 80
IBBQ Omega Ratio Rank: 71
IBBQ Calmar Ratio Rank: 92
IBBQ Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HELX vs. IBBQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Invesco Nasdaq Biotechnology ETF (IBBQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HELX	IBBQ	Difference
Sharpe ratio: Return per unit of total volatility	1.65	2.45	-0.80
Sortino ratio: Return per unit of downside risk	2.36	3.36	-1.00
Omega ratio: Gain probability vs. loss probability	1.28	1.40	-0.12
Calmar ratio: Return relative to maximum drawdown	1.96	5.89	-3.93
Martin ratio: Return relative to average drawdown	4.96	18.75	-13.80

HELX vs. IBBQ - Sharpe Ratio Comparison

The current HELX Sharpe Ratio is 1.65, which is lower than the IBBQ Sharpe Ratio of 2.45. The chart below compares the historical Sharpe Ratios of HELX and IBBQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

HELX vs. IBBQ - Drawdown Comparison

The maximum HELX drawdown since its inception was -58.75%, which is greater than IBBQ's maximum drawdown of -37.94%. Use the drawdown chart below to compare losses from any high point for HELX and IBBQ.

Drawdown Indicators

	HELX	IBBQ	Difference
Max Drawdown Largest peak-to-trough decline	-58.75%	-37.94%	-20.81%
Max Drawdown (1Y) Largest decline over 1 year	-18.01%	-8.34%	-9.67%
Max Drawdown (3Y) Largest decline over 3 years	-29.48%	-23.66%	-5.82%
Max Drawdown (5Y) Largest decline over 5 years	-58.75%	-37.94%	-20.81%
Current Drawdown Current decline from peak	-36.69%	0.00%	-36.69%
Average Drawdown Average peak-to-trough decline	-34.33%	-16.66%	-17.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.09%	2.61%	+4.48%

Volatility

HELX vs. IBBQ - Volatility Comparison

Franklin Genomic Advancements ETF (HELX) and Invesco Nasdaq Biotechnology ETF (IBBQ) have volatilities of 6.84% and 6.82%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HELX	IBBQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.84%	6.82%	+0.02%
Volatility (6M) Calculated over the trailing 6-month period	16.93%	15.72%	+1.21%
Volatility (1Y) Calculated over the trailing 1-year period	21.37%	20.03%	+1.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.14%	21.92%	+2.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.36%	21.87%	+5.49%

HELX vs. IBBQ - Expense Ratio Comparison

HELX has a 0.50% expense ratio, which is higher than IBBQ's 0.00% expense ratio.

Dividends

HELX vs. IBBQ - Dividend Comparison

HELX's dividend yield for the trailing twelve months is around 0.39%, less than IBBQ's 0.83% yield.

Position	TTM	2025	2024	2023	2022	2021	2020
HELX Franklin Genomic Advancements ETF	0.39%	0.39%	0.00%	0.00%	0.00%	0.24%	0.12%
IBBQ Invesco Nasdaq Biotechnology ETF	0.83%	0.90%	1.14%	0.81%	0.76%	0.63%	0.00%

Frequently Asked Questions

Can I hold both HELX and IBBQ in my portfolio?

HELX and IBBQ have a correlation of 0.83, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HELX or IBBQ?

HELX has higher volatility (6.84%) compared to IBBQ (6.82%). In terms of maximum drawdown, HELX dropped -58.75% vs IBBQ's -37.94%.

Which ETF is better, HELX or IBBQ?

On 5-year performance, IBBQ leads with 4.77% vs -5.27% for HELX. On fees, IBBQ is cheaper at 0.00% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, HELX or IBBQ?

Over the 5-year period, IBBQ has performed better with a 4.77% return vs -5.27%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, HELX or IBBQ?

IBBQ is cheaper with a 0.00% expense ratio, compared with 0.50% for HELX.

Which ETF pays a higher dividend yield, HELX or IBBQ?

IBBQ has the higher dividend yield at 0.83%, compared with 0.39% for HELX.

What is the main difference between HELX and IBBQ?

They also come from different issuers: Franklin Templeton and Invesco. Their fees differ too: 0.50% for HELX and 0.00% for IBBQ.

Which has better risk-adjusted returns?

IBBQ currently has the higher Sharpe Ratio (2.45 vs 1.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.